首页|Flt3L、TGF-β1及EGFR与急性髓系白血病患者不良预后的关系

Flt3L、TGF-β1及EGFR与急性髓系白血病患者不良预后的关系

扫码查看
目的 探究FMS样酪氨酸激酶3配体(Flt3L)、转化生长因子β1(TGF-β1)及表皮生长因子受体(EGFR)与急性髓系白血病(AML)患者不良预后的关系.方法 选取120例首次确诊AML患者作为观察组,募集同期体检的100例健康志愿者为对照组,比较2组的Flt3L、TGF-β1及EGFR水平.观察组患者出院后随访3~12个月,根据预后情况将患者分为良好组(86例)和不良组(34例),比较2组的临床资料,采用COX模型分析上述指标与患者不良预后的关系,采用受试者工作特征(ROC)曲线探究上述指标对AML患者不良预后的预测效能.结果 观察组Flt3L、TGF-[31水平低于对照组,EGFR水平高于对照组,差异有统计学意义(P<0.05).不同预后AML患者的Flt3L、TGF-β1及EGFR水平比较差异有统计学意义(P<0.05);COX模型分析显示Flt3L、TGF-β1及EGFR水平为AML患者预后不良的独立影响因素(P<0.05).经ROC曲线分析显示,Flt3L、TGF-β1及EGFR水平预测AML患者预后不良的AUC为0.874、0.838、0.858.结论 Flt3L、TGF-β1及EGFR与AML患者不良预后相关.
Relationship Between Flt3L,TGF-β1 and EGFR and Poor Prognosis in Patients with Acute Myelogenous Leukemia
Objective To explore whether ROCK2 affects invasion and metastasis of liver cancer cells by regulating MKP1 expression.Methods 120 patients with firstly-diagnosed AML were selected as the observation group,and 100 healthy volunteers who underwent physical examination during the same period were recruited as the control group.The levels of Flt3L,TGF-β1 and EGFR were compared between the 2 groups.The patients in the observation group were followed up for 3 to 12 months after discharge,and were divided into good group(86 cases)and poor group(34 cases)according to the prognosis sta-tus.The clinical data of the 2 groups were compared,and COX model was used to analyze the relationship between the above indi-cators and poor prognosis,and receiver operating characteristic(ROC)curve was adopted to explore the predictive efficiency of the above indicators on poor prognosis in patients with AML.Results The levels of Flt3L and TGF-β1 in the observation group were lower than those in the control group while the level of EGFR was higher than that in the control group(P<0.05).There were statistical differences in the levels of Flt3L,TGF-β1 and EGFR among patients with different prognosis status(P<0.05).COX model analysis showed that the levels of Flt3L,TGF-β1 and EGFR were independent influencing factors for poor prognosis in AML patients(P<0.05).ROC curve analysis revealed that the AUCs of levels of Flt3L,TGF-β1 and EGFR in predicting the poor prognosis in patients with AML were 0.874,0.838 and 0.858 respectively.Conclusion Flt3L,TGF-β1 and EGFR are as-sociated with poor prognosis in patients with AML.

Fms-related tyrosine kinase 3 ligandTransforming growth factor β1Epidermal growth factor receptorAcute myelogenous leukemiaPrognosis

高磊、赵梅、魏兴禹

展开 >

466000 河南省周口市中心血站

466000 河南省周口市第二人民医院

466000 河南省周口开元医院

FMS样酪氨酸激酶3配体 转化生长因子β1 表皮生长因子受体 急性髓系白血病 预后

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(1)
  • 9